Profile
| Metric | Value |
|---|---|
| Full Name | Hims & Hers Health, Inc. |
| Ticker | NYSE: HIMS |
| Exchange | NYSE |
| Sector | Consumer Defensive |
| Industry | Household & Personal Products |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | hims.com |
| Employees | 1,637 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $32.34 | |
| Price, 1D Change | +2.05% | |
| Market Cap | $7B | |
| - | ||
| PE Ratio | 59.79 | |
| Beta | 2.17 | |
| Revenue | $1B | |
| Revenue, 1Y Change | +69.33% | |
| EPS | $0.53 | |
| EPS, 1Y Change | +573.07% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | OAC | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $0.53 | |
| EPS Estimate | $0.48 | |
| EPS Est. Change | -10.24% | |
| Revenue | $1.48B | |
| Revenue Estimate | $2.35B | |
| Revenue Est. Change | +58.89% | |
| Current Price | $32.34 | |
| Price Target | - | $40.00 |
| Price Tgt. Change | - | +23.69% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.14 | -$0.11 | +19.64% | |
| $0.85 | $0.53 | -37.20% | |
| $0.48 | N/A | -10.24% | |
| $0.64 | N/A | +20.97% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $871.35M | $872.00M | +0.07% | |
| $1.46B | $1.48B | +0.92% | |
| $2.35B | N/A | +58.89% | |
| $2.76B | N/A | +87.16% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +27.27% | |
| Price, 3Y | +355.49% | |
| Market Cap, 1Y | +31.20% | |
| Market Cap, 3Y | +397.49% | |
| Revenue, 1Y | +69.32% | |
| Revenue, 3Y | +443.08% | |
| EPS, 1Y | +573.07% | |
| EPS, 3Y | +192.33% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $32.34 | |
| SMA 200 | $45.75 | |
| SMA 200 vs Price | +41.47% | |
| SMA 50 | $37.21 | |
| SMA 50 vs Price | +15.06% | |
| Beta | 2.17 | |
| ATR | $1.94 | |
| 14-Day RSI | 37.62 | |
| 10-Day Volatility | 54.01% | |
| 1-Year Volatility | 104.61% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $1.48B | |
| EPS | $0.53 | |
| Gross Profit | $1.17B | |
| Gross Margin | 79.45% | |
| Operating Profit | $61.90M | |
| Operating Margin | 4.19% | |
| Net Income | $126.04M | |
| Net Margin | 8.54% | |
| EBITDA | $78.99M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.00 | |
| Current Ratio | 1.79 | |
| Quick Ratio | 1.50 | |
| - | ||
| F-Score | 4 | |
| Altman Z-Score | 19.95 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 59.79 | |
| PS Ratio | 3.33 | |
| PB Ratio | 12.67 | |
| EV/EBITDA | 45.04 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $476.72M | |
| Cash & Equivalents | $220.58M | |
| Total Assets | $724.81M | |
| Current Assets | $395.83M | |
| Total Liabilities | $248.09M | |
| Current Liabilities | $221.37M | |
| Total Debt | $11.35M | |
| Short Term Debt | $1.89M | |
| Accounts Payable | $91.18M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $1.41B | |
| Operating Expenses | $1.11B | |
| Cost Of Goods Sold | $303.38M | |
| SG&A | $846.61M | |
| D&A | $17.09M | |
| Interest Expense | $0.00 | |
| Income Tax | -$54.33M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $251.08M | |
| CFI | -$19.05M | |
| CFF | -$107.85M | |
| Capex | $52.75M | |
| Free Cash Flow | $198.33M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Barclays | ||
| BTIG | → | |
| B of A Securities | → | |
| Keybanc | ||
| Canaccord Genuity | → | |
| Truist Securities | → | |
| Needham | → | |
| Truist Securities | → | |
| Morgan Stanley | → | |
| Needham | → |
Analyst sentiment
Institutional ownership
Screeners with HIMS
Data Sources & References
- HIMS Official Website www.hims.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1773751/000177375125000354/0001773751-25-000354-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1773751/000177375125000062/0001773751-25-000062-index.htm
- HIMS Profile on Yahoo Finance finance.yahoo.com/quote/HIMS
- HIMS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/hims
FAQ
What is the ticker symbol for Hims & Hers Health, Inc.?
The ticker symbol for Hims & Hers Health, Inc. is NYSE:HIMS
Does Hims & Hers Health, Inc. pay dividends?
No, Hims & Hers Health, Inc. does not pay dividends
What sector is Hims & Hers Health, Inc. in?
Hims & Hers Health, Inc. is in the Consumer Defensive sector
What industry is Hims & Hers Health, Inc. in?
Hims & Hers Health, Inc. is in the Household & Personal Products industry
What country is Hims & Hers Health, Inc. based in?
Hims & Hers Health, Inc. is headquartered in United States
When did Hims & Hers Health, Inc. go public?
Hims & Hers Health, Inc. initial public offering (IPO) was on September 13, 2019
Is Hims & Hers Health, Inc. in the S&P 500?
No, Hims & Hers Health, Inc. is not included in the S&P 500 index
Is Hims & Hers Health, Inc. in the NASDAQ 100?
No, Hims & Hers Health, Inc. is not included in the NASDAQ 100 index
Is Hims & Hers Health, Inc. in the Dow Jones?
No, Hims & Hers Health, Inc. is not included in the Dow Jones index
When was Hims & Hers Health, Inc. last earnings report?
Hims & Hers Health, Inc.'s most recent earnings report was on November 3, 2025
When does Hims & Hers Health, Inc. report earnings?
The next expected earnings date for Hims & Hers Health, Inc. is February 23, 2026